Rise and shine. Another busy day is on the way. As always, we are hustling about the Pharmalot corporate campus, trying to tend to the official mascots, the short people and other morning matters in the midst of our usual responsibilities. Thankfully, the coffee kettle is working at peak performance today, which means we are can fortify ourselves with - you guessed it - a cup of stimulation. Once again, we invite you to join us. While indulging, you can peruse some of the tidbits below. Hope your day goes well and stay in touch...
Arkansas Wants $180M In Legal Fees For Risperdal Case (Associated Press)
UK NICE Chairman Rawlins To Retire (Regulatory Focus)
KV Pharma To Emerge From Bankruptcy With $85M Loan (St. Louis Business Journal)
Opiod Blocker Helps Women Lose Weight After They Quit Smoking (Star-Ledger)
MHRA Says 1,200 API Plants May Need Inspection (InPharma Technologist)
Eisai Signa Neuroscience Alliance With UCL (Pharma Times)
Avastin Shows No Benefit For Early Colon Cancer: Study (HealthDay)
FDA Accepts Lundbeck Submission For Antidepressant (Reuters)
EDITOR'S NOTE: Please check this post for updates
kettle pic thx to mirahartford on flickr
1 Comment